Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
2.770
-0.520 (-15.81%)
At close: Dec 3, 2024, 4:00 PM
2.830
+0.060 (2.17%)
After-hours: Dec 3, 2024, 4:43 PM EST
Relmada Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1.48 | 4.09 | 5.4 | 44.44 | 2.5 | 36.28 | Upgrade
|
Short-Term Investments | 52.63 | 92.23 | 142.93 | 167.47 | 114.6 | 80.16 | Upgrade
|
Cash & Short-Term Investments | 54.12 | 96.32 | 148.32 | 211.91 | 117.09 | 116.44 | Upgrade
|
Cash Growth | -49.07% | -35.06% | -30.01% | 80.98% | 0.56% | 1163.42% | Upgrade
|
Other Receivables | - | - | 0.51 | 0.09 | 0.08 | 0.07 | Upgrade
|
Receivables | - | - | 0.51 | 0.09 | 0.08 | 0.07 | Upgrade
|
Prepaid Expenses | 1.58 | 1.19 | 4.04 | 11.3 | 0.9 | 0.42 | Upgrade
|
Total Current Assets | 55.7 | 97.51 | 152.87 | 223.3 | 118.07 | 116.94 | Upgrade
|
Property, Plant & Equipment | - | - | - | - | 0 | 0.01 | Upgrade
|
Other Long-Term Assets | 0.02 | 0.04 | 0.03 | 0.03 | 0.11 | 0.19 | Upgrade
|
Total Assets | 55.72 | 97.55 | 152.91 | 223.33 | 118.19 | 117.14 | Upgrade
|
Accounts Payable | 2.35 | 3.51 | 5.26 | 11.19 | 8.35 | 0.52 | Upgrade
|
Accrued Expenses | 5.74 | 8.69 | 7.21 | 3.87 | 4.26 | 0.57 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 0.11 | Upgrade
|
Other Current Liabilities | - | - | - | - | - | 0.25 | Upgrade
|
Total Current Liabilities | 8.09 | 12.19 | 12.47 | 15.06 | 12.6 | 1.46 | Upgrade
|
Other Long-Term Liabilities | 0.01 | - | - | - | - | - | Upgrade
|
Total Liabilities | 8.1 | 12.19 | 12.47 | 15.06 | 12.6 | 1.46 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | Upgrade
|
Additional Paid-In Capital | 669.82 | 646.23 | 602.52 | 513.3 | 284.88 | 235.52 | Upgrade
|
Retained Earnings | -622.22 | -560.9 | -462.11 | -305.07 | -179.32 | -119.86 | Upgrade
|
Total Common Equity | 47.63 | 85.36 | 140.44 | 208.26 | 105.58 | 115.68 | Upgrade
|
Shareholders' Equity | 47.63 | 85.36 | 140.44 | 208.26 | 105.58 | 115.68 | Upgrade
|
Total Liabilities & Equity | 55.72 | 97.55 | 152.91 | 223.33 | 118.19 | 117.14 | Upgrade
|
Total Debt | - | - | - | - | - | 0.11 | Upgrade
|
Net Cash (Debt) | 54.12 | 96.32 | 148.32 | 211.91 | 117.09 | 116.33 | Upgrade
|
Net Cash Growth | -49.07% | -35.06% | -30.01% | 80.98% | 0.65% | 1214.15% | Upgrade
|
Net Cash Per Share | 1.80 | 3.20 | 5.01 | 12.07 | 7.51 | 12.61 | Upgrade
|
Filing Date Shares Outstanding | 30.17 | 30.17 | 30.1 | 29.37 | 16.75 | 14.94 | Upgrade
|
Total Common Shares Outstanding | 30.17 | 30.1 | 30.1 | 27.74 | 16.33 | 14.46 | Upgrade
|
Working Capital | 47.62 | 85.31 | 140.4 | 208.24 | 105.47 | 115.48 | Upgrade
|
Book Value Per Share | 1.58 | 2.84 | 4.67 | 7.51 | 6.46 | 8.00 | Upgrade
|
Tangible Book Value | 47.63 | 85.36 | 140.44 | 208.26 | 105.58 | 115.68 | Upgrade
|
Tangible Book Value Per Share | 1.58 | 2.84 | 4.67 | 7.51 | 6.46 | 8.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.